Back

Moderate to severe renal insufficiency and risk for cardiovascular and limb outcomes in patients with symptomatic peripheral artery disease: the EUCLID trial

27 August 2018 (14:58 - 15:07)
Organised by:
Congress Presentation Part of: Peripheral and aortic disease: comorbidities and outcomes of intervention Peripheral Artery Disease ESC Premium Access ESC Congress 2018

About the speaker

Photo
Professor William Hiatt

Colorado Prevention Centre, Aurora (United States of America)

7 More presentations in this session

Presentation thumbnail
The impact of end-stage renal disease status on peripheral endovascular intervention outcome in patients with severe peripheral artery disease
Doctor M. Alraies (New York City, US)
Abstract Slides Video
Presentation thumbnail
Long-term clinical outcomes after lower limb revascularization in dialysis patients with peripheral artery disease
Doctor R. Ito (Nagoya, JP)
Abstract Slides Video
Presentation thumbnail
Effects of chronic kidney disease on clinical outcomes in patients with peripheral artery disease undergoing endovascular treatment: analysis from the K-VIS ELLA registry
Professor W. Kim (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Comparison of endovascular versus surgical revascularization for critical limb ischemia in octogenarian and nonagenarian
Associate Professor B. Yan (Hong Kong, CN)
Abstract Slides Video
Presentation thumbnail
Diabetes and acute aortic dissection: insights from the International Registry of Acute Aortic Dissection
Doctor D. Spinelli (Messina, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Peripheral and aortic disease: comorbidities and outcomes of intervention

The Event

Event poster

ESC Congress 2018

27 August 2018 14:58 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources